|
![]() |
|||
|
||||
OverviewFull Product DetailsAuthor: Robert A. Britton (Universite Paris-Saclay, Jouy-en-Josas, France) , Patrice D. Cani (Baylor College of Medicine, Houston, TX)Publisher: American Society for Microbiology Imprint: American Society for Microbiology Dimensions: Width: 17.80cm , Height: 2.80cm , Length: 25.70cm Weight: 1.247kg ISBN: 9781555819699ISBN 10: 1555819699 Pages: 514 Publication Date: 01 February 2018 Audience: Professional and scholarly , Professional & Vocational Format: Hardback Publisher's Status: Active Availability: In Print ![]() This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us. Table of ContentsReviewsBecause microbiome research studies are being published at an unprecedented rate, a reliable book that reviews the seminal work and knowledge gaps in this field is pressingly needed. In Bugs as Drugs: Therapeutic Microbes for the Prevention and Treatment of Disease, the authors address major themes in microbiome research, particularly focusing on therapeutic applications. This ~500-page volume, edited by Robert A. Britton and Patrice D. Cani, comprises 5 main sections of varying scope and length. The introductory section reviews pathways used by commensals, particularly Lactobacilli and Bifidobacteria spp., to benefit the host. The first chapter is particularly impressive, providing a thorough and well-cited overview of the various microbial metabolites and how they influence the host. ...Overall, this book is a commendable and timely volume of well-sourced reviews written by experts in the field well organized into broad research themes. This work will serve as a helpful resource for both scientists and clinicians interested in using microbes for therapeutic applications. -Excerpted from the full review in Emerging Infectious Diseases, Vol. 25, No.7, Books and Media Because microbiome research studies are being published at an unprecedented rate, a reliable book that reviews the seminal work and knowledge gaps in this field is pressingly needed. In Bugs as Drugs: Therapeutic Microbes for the Prevention and Treatment of Disease, the authors address major themes in microbiome research, particularly focusing on therapeutic applications. This ~500-page volume, edited by Robert A. Britton and Patrice D. Cani, comprises 5 main sections of varying scope and length. The introductory section reviews pathways used by commensals, particularly Lactobacilli and Bifidobacteria spp., to benefit the host. The first chapter is particularly impressive, providing a thorough and well-cited overview of the various microbial metabolites and how they influence the host. ...Overall, this book is a commendable and timely volume of well-sourced reviews written by experts in the field well organized into broad research themes. This work will serve as a helpful resource for both scientists and clinicians interested in using microbes for therapeutic applications. -Excerpted from the full review in Emerging Infectious Diseases, Vol. 25, No.7, Books and Media Because microbiome research studies are being published at an unprecedented rate, a reliable book that reviews the seminal work and knowledge gaps in this field is pressingly needed. In Bugs as Drugs: Therapeutic Microbes for the Prevention and Treatment of Disease, the authors address major themes in microbiome research, particularly focusing on therapeutic applications. This 500-page volume, edited by Robert A. Britton and Patrice D. Cani, comprises 5 main sections of varying scope and length. The introductory section reviews pathways used by commensals, particularly Lactobacilli and Bifidobacteria spp., to benefit the host. The first chapter is particularly impressive, providing a thorough and well-cited overview of the various microbial metabolites and how they influence the host. ...Overall, this book is a commendable and timely volume of well-sourced reviews written by experts in the field well organized into broad research themes. This work will serve as a helpful resource for both scientists and clinicians interested in using microbes for therapeutic applications. -Excerpted from the full review in Emerging Infectious Diseases, Vol. 25, No.7, Books and Media Author InformationRobert A. Britton, Micalis Institute, INRA, AgroParisTech, Université Paris-Saclay, Jouy-en-Josas, France. Patrice D. Cani, Baylor College of Medicine, Molecular Virology and Microbiology, Houston, Texas. Tab Content 6Author Website:Countries AvailableAll regions |